The Current Ratio as of September 2024 (TTM) for 9 Meters Biopharma, Inc. (NMTR) is 0.59

According to 9 Meters Biopharma, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.59. This represents a change of -63.42% compared to the average of 1.61 of the last 4 quarters.

9 Meters Biopharma, Inc. (NMTR) Historical Current Ratio (quarterly & annually)

How has NMTR Current Ratio performed in the past?

The mean historical Current Ratio of 9 Meters Biopharma, Inc. over the last ten years is 1.64. The current 0.59 Current Ratio has changed 3.50% with respect to the historical average. Over the past ten years (40 quarters), NMTR's Current Ratio was at its highest in in the June 2021 quarter at 9.80. The Current Ratio was at its lowest in in the September 2014 quarter at 0.

9 Meters Biopharma, Inc. (NMTR) Current Ratio by Quarter and Year

Discovering the peaks and valleys of 9 Meters Biopharma, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

9 Meters Biopharma, Inc. (NMTR) Average Current Ratio

How has NMTR Current Ratio performed in the past?

The current Current Ratio of 9 Meters Biopharma, Inc. (NMTR) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

9 Meters Biopharma, Inc. (NMTR) Current Ratio vs. Peers

How is NMTR’s Current Ratio compared to its peers?

9 Meters Biopharma, Inc.’s Current Ratio is less than Mereo BioPharma Group plc (6.07), less than Acumen Pharmaceuticals, Inc. (17.37), less than Day One Biopharmaceuticals, Inc. (4.09), less than Inozyme Pharma, Inc. (9.84), less than Galera Therapeutics, Inc. (5.63), less than Aileron Therapeutics, Inc. (4.69), less than Artelo Biosciences, Inc. (14.58), less than Histogen Inc. (4.05), less than Curis, Inc. (1.78), greater than Timber Pharmaceuticals, Inc. (0.50), greater than Kineta, Inc. (0.14), less than Candel Therapeutics, Inc. (1.62), less than MiNK Therapeutics, Inc. (0.93), less than Forte Biosciences, Inc. (2.82), less than AlloVir, Inc. (55.08), greater than ZIVO Bioscience, Inc. (0.17), less than RenovoRx, Inc. (4.39), less than Tempest Therapeutics, Inc. (2.17), less than Ikena Oncology, Inc. (18.22), greater than Catalyst Biosciences, Inc. (0), less than MEI Pharma, Inc. (6.17), less than Magenta Therapeutics, Inc. (14.64), less than Kezar Life Sciences, Inc. (9.58), less than Vincerx Pharma, Inc. (3.43), less than Avenue Therapeutics, Inc. (4.30),

Build a custom stock screener for 9 Meters Biopharma, Inc. (NMTR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like 9 Meters Biopharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

9 Meters Biopharma, Inc. (NMTR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like 9 Meters Biopharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.